美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Americann Inc.

0.0001

0.0000

成交量：- -

成交額：- -

市值：2,439.20

市盈率：0.00

高：0.0001

開：0.0001

低：0.0001

收：0.0001

52周最高：0.1201

52周最低：0.0000

股本：2,439.20萬

流通股本：1,373.84萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.0976

每股收益(LYR):-0.0514

淨資產收益率：-54.80%

總資產收益率：-5.74%

市淨率：0.00

市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告

BioMarin暫停骨骼疾病療法的中期臨床試驗

环球市场播报

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ACAN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACAN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACAN\",,,,,undefined,":{"symbol":"ACAN","market":"US","secType":"STK","nameCN":"Americann Inc.","latestPrice":0.0001,"timestamp":1773770160000,"preClose":0.0001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":13738420,"shares":24391961,"eps":-0.097615,"marketStatus":"交易中","change":0,"latestTime":"03-17 13:56:00 EDT 延時","open":0.0001,"high":0.0001,"low":0.0001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.097615,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773777600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0001,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACAN\",,,,,undefined,":{"symbol":"ACAN","floatShares":13738420,"roa":"-5.74%","roe":"-54.80%","lyrEps":-0.051423,"shares":24391961,"dividePrice":0,"high":0.0001,"amplitude":0,"preClose":0.0001,"low":0.0001,"week52Low":0.000001,"pbRate":"0.00","psRate":"0.00","week52High":0.12005,"institutionHeld":0,"latestPrice":0.0001,"eps":-0.097615,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.097615,"open":0.0001,"prevYearClose":0.0001,"prevWeekClose":0.0001,"prevMonthClose":0.0002,"prevQuarterClose":0.0001,"fiveDayClose":0.0001,"twentyDayClose":0.0001,"sixtyDayClose":0.0001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACAN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-14","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-14","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1707886800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-12-22","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1703221200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-14","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1691985600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-02-16","symbol":"ACAN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1676523600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACAN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACAN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACAN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619464520","title":"BioMarin暫停骨骼疾病療法的中期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2619464520","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619464520?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 22:42","pubTimestamp":1773672120,"startTime":"0","endTime":"0","summary":"BioMarin 制药公司周一宣布，在报告多例患者髋关节脱位事件后，将终止一款骨骼疾病疗法的中期临床试验，消息导致其股价下跌 4%。BioMarin 当时正在对其药物 Voxzogo 进行临床试验，用于治疗特纳综合征、SHOX 基因缺陷及聚集蛋白聚糖缺陷患者。BioMarin 表示，将继续在努南综合征患者及一类原因不明的身材矮小患者中测试该药物。上月，FDA 批准了 Ascendis 制药公司的每周一次注射剂 Yuviwel，使其成为第二款在美国获批用于软骨发育不全的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-16/doc-inhrezkk2594890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ACAN","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}